Skip to main content
Caplight Logo









Pep2Tango Therapeutics Inc.

Pep2Tango Therapeutics Inc.

Private
Potomac, MarylandHealthcare & Life Scienceshttps://www.pep2tango.com/

Last Round

VC Round

Nov 21, 2024

Company Overview

Pep2Tango Therapeutics Inc. is a biotechnology company developing next-generation unimolecular multi-agonist peptides for obesity and associated metabolic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

peptide therapiesobesity treatmenttetra-receptor agonistunimolecular peptideGLP-1 agonistanti-obesity drugsmuscle-sparing weight lossnext-gen obesity drugmulti-agonist obesity drugGIP agonistmetabolic disorder treatmentdrug discoverypreclinical biotechnologyamylin agonistcalcitonin agonist

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pep2Tango Therapeutics Inc. Comparables

Compare Pep2Tango Therapeutics Inc. with similar companies based on industry and business-model similarity.

Pep2Tango Therapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AstraZeneca
83%
Alveus Therapeutics
82%
Antag Therapeutics
75%

Pep2Tango Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 21, 2024

Key People

Founding team and executive leadership

Cristina Rondinone

Founder And CEO

Founding Team

Pep2Tango Therapeutics Inc. Investors

Notable investors and investment history

Pep2Tango Therapeutics Inc. investors
InvestorRounds
Versant VenturesVC Round

Pep2Tango Therapeutics Inc. Filings

Explore SEC and related filing metadata, where available.

Pep2Tango Therapeutics Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pep2Tango Therapeutics Inc.'s valuation, stock price, and market status.

Is Pep2Tango Therapeutics Inc. a public or private company?

Pep2Tango Therapeutics Inc. is a private company.

What is the current stock price of Pep2Tango Therapeutics Inc.?

Pep2Tango Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Pep2Tango Therapeutics Inc. worth (valuation)?

Valuation information for Pep2Tango Therapeutics Inc. is not publicly available.

Can I buy Pep2Tango Therapeutics Inc. stock?

Pep2Tango Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pep2Tango Therapeutics Inc.'s last funding round?

Funding round information for Pep2Tango Therapeutics Inc. is not publicly available.

Who are the main investors in Pep2Tango Therapeutics Inc.?

Investor information for Pep2Tango Therapeutics Inc. is not publicly disclosed.

Will Pep2Tango Therapeutics Inc. IPO soon?

No public IPO plans have been announced for Pep2Tango Therapeutics Inc..

How can I track Pep2Tango Therapeutics Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pep2Tango Therapeutics Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPotomac, Maryland
Employee Range4
Year Founded2021
Last FundingNov 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?